A number of ligands, including CXCL1, CXCL2, CXCL5, and CXCL8, converge on CXCR2, thereby coordinating neutrophil recruitment, angiogenesis, epithelial–mesenchymal transition, and tumor proliferation. Here, CXCL2 is linked to neoplasm.